Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Drug Resistance
75%
Malignant Neoplasm
70%
Cysteine
50%
Phosphotransferase
50%
Pancreas Cancer
50%
Butein
50%
Therapy Resistance
50%
Drug Repositioning
50%
Myeloma
36%
Pancreas Adenocarcinoma
35%
Ospemifene
35%
Breast Cancer
32%
Carcinogen
30%
Carcinogenesis
29%
Nuclear Factor
29%
Alternative Complement Pathway C3 C5 Convertase
29%
STAT3 Protein
29%
Betulinic Acid
25%
Hematologic Malignancy
25%
Protein Tyrosine Phosphatase SHP 1
25%
Repurposing
25%
Quinoxaline
25%
Epidermal Growth Factor
25%
Transferrin Receptor
25%
Natural Product
25%
Arthritis
25%
Berberine
25%
Liver Cell Carcinoma
25%
Sesamin
25%
Bruton Tyrosine Kinase Inhibitor
25%
Catenin
25%
Bruton Tyrosine Kinase
25%
Death Receptor 5
25%
Colon Cancer
25%
Gossypol
25%
Chemokine Receptor
25%
Isothiocyanate
25%
Thiol
25%
Alpha Chemokine
25%
Aldehyde Dehydrogenase Inhibitor
25%
Aldehyde Dehydrogenase
25%
Cyclin Dependent Kinase 6
25%
Fisetin
25%
Vasculotropin Receptor 2
25%
Prostate Tumor
25%
Prodrug
25%
Transforming Growth Factor Beta Activated Kinase 1
25%
Gossypine
25%
Flavone
25%
Keyphrases
Pancreatic Carcinogenesis
25%
Myeloma Cells
25%
SHP-1
25%
Betulinic Acid
25%
Activation Mechanism
25%
Lymphoma
25%
Protein Tyrosine Phosphatase 1B (PTP1B)
25%
STAT3 Activation
25%
Isoselenoureas
25%
Direct Inhibitors
25%
B-factor
25%
Repurposing
25%
Approved Drugs
25%
Cancer Therapy
25%
Quinoxaline
25%
Epidermal Growth Factor
25%
Medicine Recognition
25%
Development Review
25%
Microbiome
25%
Modern Medicine
25%
Mesenchymal Cells
25%
Dynein Light Chain
25%
Mitotic Delay
25%
Km23-1
25%
Arthritis Treatment
25%
Sesamin
25%
Bruton Tyrosine Kinase Inhibitor
25%
STAT3 Phosphorylation
25%
Angiogenesis-related Genes
25%
Survival Genes
25%
Human Ovarian Carcinoma Cells
25%
Natural Products
25%
HepG2 Cell Line
25%
Berberine
25%
Novel Ligands
25%
Transferrin Receptor 1 (TfR1)
25%
Arthritis
25%
Human Hepatoma
25%
Targeted Cells
25%
Athymic Mice
25%
C-Fos
25%
Drug Efflux Pump
25%
Dual Control
25%
Epigenetic Regulation
25%
Pediatric Cancer
25%
Invasion Genes
25%
Cancer Comorbidity
25%
Cancer Cell Death
25%
Survival Proteins
25%
Therapeutic Challenges
25%
Medicine and Dentistry
Hematologic Malignancy
25%
Ganglioneuroblastoma
25%
Cisplatin
25%
Bruton Tyrosine Kinase
25%
Epidermal Growth Factor
25%
Limb Bud
25%
Cell Survival
25%
Sesamin
25%
Antineoplastic Activity
25%
Bruton Tyrosine Kinase Inhibitor
25%
Signal Transduction
25%
Chemokine Receptor
25%
Alpha Chemokine
25%
Multiple Myeloma
25%
Nuclear Factor
25%
Prostate Tumor
25%
Vasculotropin Receptor 2
25%
G1/S Transition
25%
Alternative Complement Pathway C3 C5 Convertase
25%
Flavone
25%
Gossypine
25%
Transforming Growth Factor Beta Activated Kinase 1
25%
Monoclonal Gammopathy of Undetermined Significance
25%
Neuropathy
25%
Immunoglobulin M
25%
Bortezomib
25%
Acute Pancreatitis
25%
Naphthalimide Derivative
25%
DNA Topoisomerase (ATP Hydrolysing)
25%
Developmental Abnormality
25%
Pancreas Adenocarcinoma
25%
Pancreas Cancer
25%
Death Receptor
25%
Stomach Ulcer
25%
Stomach Cancer
25%
Benzophenone
25%
Ospemifene
25%
Therapy Resistance
25%
Drug Repositioning
25%
Gamma Chemokine
25%
Melanoma
25%
Triple Negative Breast Cancer
25%
Tamoxifen
15%
Malignant Neoplasm
10%
Cre Recombinase
10%
Cancer Prevention
10%
Osteosarcoma
9%
Ibrutinib
8%
Rituximab
8%
Paresthesia
8%